Showing results (1471-1480 of 3,189) with videos related to
Sort By:
Pageof 319
Translational Oncology|May 29, 2026
Combined treatment of TROP‑2 targeted CAR-T and vascular disruptor CBP enhances anti‑tumor activity in triple‑negative breast cancerYizhu Chen, LiSheng Wang, Jian Jiang, et al.Translational Oncology|May 12, 2026
Single-cell RNA sequencing reveals immune microenvironment heterogeneity in BRCA1-mutated and sporadic triple-negative breast cancerQi Sun, Yuting Zhong, Changgang SunTranslational Oncology|May 11, 2026
Feiyanning formula inhibits metastasis and differentiation of osteoclasts by targeting miR-328/NF-κB signaling axis via exosomal HOTAIR in lung cancer cellsChengcheng Zhang, Yiyi Liu, Zhanhui Lu, et al.Translational Oncology|May 18, 2026
Combination of APS, HMGN1, and anti-TNFR2 antibody remodels the tumor immune microenvironment to enhance antitumor immunity in colorectal cancerLiming Zhao, Xia Pei, Haobo Wu, et al.Translational Oncology|May 15, 2026
Multi-Omics profiling identify NNMT in tumor endothelium as a key regulator of CD8⁺ T cell exhaustion via the TGF signaling pathwayLexin Wang, Honglin He, Ke Su, et al.Translational Oncology|March 17, 2026
Exploiting cellular senescence in hematologic malignanciesPeijie Jiang, Guancui Yang, Jiarun Li, et al.Translational Oncology|February 21, 2026
SELE is associated with reduced breast cancer susceptibility: Evidence from Mendelian randomization and single-cell transcriptomeHanghang Chen, Weihua Hu, Ruidong Liu, et al.Translational Oncology|February 22, 2026
Cystic lesions and their role in pancreatic cancer risk stratificationRebecca Lyons, Stephen G Maher, Joanne LysaghtTranslational Oncology|April 4, 2026
Unmasking FCGR2B as a high-grade serous ovarian cancer specific marker of immune suppression and tumor progression through multi-omics miningJialu Zhou, Tao Zeng, Mingxia Ye, et al.Translational Oncology|May 2, 2026
Eprenetapopt in combination with Palbociclib exerts synthetic lethality in mantle cell lymphomaLing Dong, Yue Zhang, Fei Chen, et al.Pageof 319